Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A

Phase 4

Completed

Conditions: Hemophilia A

Interventions: Drug: Intravenous infusions of Xyntha

First Posted Date: 2015-07-09

Last Posted Date: 2017-04-04

Lead Sponsor: Pfizer

Target Recruit Count: 85

Registration Number: NCT02492984

Locations: 🇨🇳
The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China
🇨🇳
Henan Provincial People's Hospital, Zhengzhou, Henan, China
🇨🇳
Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China

and more 12 locations

A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)

Phase 1

Completed

Conditions: Renal Cell Cancer

Interventions: Drug: Avelumab (MSB0010718C)
Drug: Axitinib (AG-013736)

First Posted Date: 2015-07-09

Last Posted Date: 2022-02-18

Lead Sponsor: Pfizer

Target Recruit Count: 55

Registration Number: NCT02493751

Locations: 🇯🇵
Kindai University Hospital, Osakasayama, Osaka, Japan
🇯🇵
Keio University Hospital, Shinjuku-ku, Tokyo, Japan
🇺🇸
Scottsdale Healthcare Hospitals d/b/a HonorHealth, Scottsdale, Arizona, United States

and more 17 locations

A Study To Evaluate The Effect Of Food On The Behavior of Tofacitinib Modified Release 22 Milligram Tablets In Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Tofacitinib MR 22 mg (Fed)
Drug: Tofacitinib MR 22 mg (Fasted)

First Posted Date: 2015-07-01

Last Posted Date: 2015-08-19

Lead Sponsor: Pfizer

Target Recruit Count: 18

Registration Number: NCT02487433

Locations: 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium

A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

Completed

Conditions: Psoriatic Arthritis
Rheumatoid Arthritis
Plaque Psoriasis
Axial Spondyloarthritis

Interventions: Drug: Etanercept

First Posted Date: 2015-07-01

Last Posted Date: 2019-06-24

Lead Sponsor: Pfizer

Target Recruit Count: 1534

Registration Number: NCT02486302

Locations: 🇩🇪
Rheumatologisches MVZ Dresden GmbH im Gesundheitszentrum Dresden - Klotzsche (GZDK), Dresden, Sachsen, Germany
🇩🇪
private practise Schmitt-Haendle, Bayreuth, Germany
🇩🇪
private practise Hemmerich, Aachen, Germany

and more 177 locations

Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-06650833
Drug: Placebo

First Posted Date: 2015-06-30

Last Posted Date: 2018-04-19

Lead Sponsor: Pfizer

Target Recruit Count: 71

Registration Number: NCT02485769

Locations: 🇺🇸
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States

A Gene Therapy Study for Hemophilia B

Phase 2

Completed

Conditions: Hemophilia B

Interventions: Biological: SPK-9001

First Posted Date: 2015-06-29

Last Posted Date: 2020-06-16

Lead Sponsor: Pfizer

Target Recruit Count: 15

Registration Number: NCT02484092

Locations: 🇺🇸
Weill Cornell Medicine - New York Presbyterian Hospital, New York, New York, United States
🇺🇸
University of Mississippi Medical Center, Jackson, Mississippi, United States
🇺🇸
UC Davis Comprehensive Cancer Center, Sacramento, California, United States

and more 7 locations

A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).

Phase 3

Completed

Conditions: Rheumatoid Arthritis

Interventions: Biological: PF-06410293
Biological: Adalimumab

First Posted Date: 2015-06-24

Last Posted Date: 2019-01-23

Lead Sponsor: Pfizer

Target Recruit Count: 597

Registration Number: NCT02480153

Locations: 🇺🇸
Robert W. Levin, MD, PA, Clearwater, Florida, United States
🇿🇦
Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, Gauteng, South Africa
🇺🇸
SIMED Arthritis Center, Gainesville, Florida, United States

and more 179 locations

Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).

Phase 2

Completed

Conditions: Complicated Intra-abdominal Infections

Interventions: Drug: Ceftazidime -avibactam
Drug: Meropenem
Drug: Metronidazole

First Posted Date: 2015-06-19

Last Posted Date: 2018-08-09

Lead Sponsor: Pfizer

Target Recruit Count: 83

Registration Number: NCT02475733

Locations: 🇺🇸
CHOC Children's, Orange, California, United States
🇨🇿
Oblastni Nemocnice Kolin, a.s., Nemocnice Stredoceskeho Kraje, Detske oddeleni, Kolin III, Czechia
🇺🇸
Rady Children's Hospital San Diego, San Diego, California, United States

and more 32 locations

An Open-label, Two-period, Fixed-sequence Study to Evaluate Multiple-dose Itraconazole Effect on The Single-dose PK of PF-06372865 in Healthy Subjects

Phase 1

Withdrawn

Conditions: Healthy

Interventions: Drug: PF-06372865
Drug: itraconazole

First Posted Date: 2015-06-19

Last Posted Date: 2017-06-26

Lead Sponsor: Pfizer

Registration Number: NCT02475746

Locations: 🇺🇸
Pfizer New Haven Clinical Research Unit, New Haven, Connecticut, United States
🇺🇸
CRU New Haven, New Haven, Connecticut, United States

Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients

Conditions: Neoplasm

First Posted Date: 2015-06-16

Last Posted Date: 2024-06-26

Lead Sponsor: Pfizer

Registration Number: NCT02473497

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
🇺🇸
Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States

and more 13 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy